Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-MAG Neuropathy”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT02967679
What this trial is testing

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more
MedDay Pharmaceuticals SA 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07392229
What this trial is testing

Zanubritnib and Anti-MAG Neuropathy

Who this might be right for
Anti-MAG IgM-associated Demyelinating Polyneuropathy
Azienda Ospedaliera di Padova 50
Early research (Phase 1)Ended earlyNCT03701711
What this trial is testing

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

Who this might be right for
Demyelinating Sensorimotor Neuropathy
Ohio State University 11
Not applicableStudy completedNCT03397303
What this trial is testing

Quantification of Nerve Stiffness in Neuropathies

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyCharcot-Marie-Tooth Disease, Type IAAnti-MAG Neuropathy
Nantes University Hospital 36
Not applicableEnded earlyNCT02468596
What this trial is testing

Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy

Who this might be right for
Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
Fondation Ophtalmologique Adolphe de Rothschild 6
Large-scale testing (Phase 3)Looking for participantsNCT05136976
What this trial is testing

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

Who this might be right for
Anti-MAG Neuropathy
Centre Hospitalier Universitaire de Saint Etienne 90
Not applicableStudy completedNCT03268161
What this trial is testing

Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies

Who this might be right for
Neuropathy Demyelinating
Rennes University Hospital 26
Not applicableUnknownNCT04844203
What this trial is testing

Prevalence of Orthostatic Tremor in Patients With Unsteadiness

Who this might be right for
Orthostatic TremorNeuropathy
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Study completedNCT00050245
What this trial is testing

Rituximab to Treat Neuropathy With Anti-MAG Antibodies

Who this might be right for
Polyneuropathies
National Institute of Neurological Disorders and Stroke (NINDS) 30
Not applicableLooking for participantsNCT03918421
What this trial is testing

Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

Who this might be right for
Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy
Hospices Civils de Lyon 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05065554
What this trial is testing

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Who this might be right for
IgM MGUSWaldenstrom MacroglobulinemiaNeuropathy;Peripheral
Shayna Sarosiek, MD 12
Not applicableLooking for participantsNCT07461896
What this trial is testing

Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP

Who this might be right for
Charcot-Marie-ToothCMT1AChronic Inflammatory Demyelinating Polyneuropathy (CIDP)+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 39
Testing effectiveness (Phase 2)Ended earlyNCT04568174
What this trial is testing

First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy

Who this might be right for
Anti-MAG Neuropathy
Polyneuron Pharmaceuticals AG 1